
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $4.3B | $4.5B | $4.5B | $4.2B | $4.5B | |
Revenue Growth (YoY) | -1.32% | 4.07% | 0.9% | -7.4% | 6.1% | |
Cost of Revenues | $3.7B | $3.8B | $3.8B | $3.4B | $3.6B | |
Gross Profit | $579.8M | $673M | $767.8M | $807.1M | $878.6M | |
Gross Profit Margin | 13.44% | 14.99% | 16.95% | 19.24% | 19.74% | |
R&D Expenses | $235.1M | $300.8M | $295.7M | $307.7M | $330.1M | |
Selling, General & Admin | $230.5M | $265.9M | $222.7M | $295.5M | $373M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $459.3M | $553.5M | $512.7M | $595.8M | $695.6M | |
Operating Income | $120.4M | $119.5M | $255.1M | $211.4M | $183.1M | |
Net Interest Expenses | -- | $1.7M | $13.7M | $33.2M | $48M | |
EBT. Incl. Unusual Items | $116.5M | $167.3M | $248M | $179.5M | $220.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $73.9M | $30.5M | $77.6M | $49.9M | $66.2M | |
Net Income to Company | $116.5M | $167.3M | $248M | $179.5M | $220.5M | |
Minority Interest in Earnings | -$66K | $842K | -$723K | -$605K | -$613K | |
Net Income to Common Excl Extra Items | $42.5M | $137.6M | $169.6M | $129M | $153.7M | |
Basic EPS (Cont. Ops) | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 | |
Diluted EPS (Cont. Ops) | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 | |
Weighted Average Basic Share | $6.7B | $6.8B | $7B | $7.1B | $7.1B | |
Weighted Average Diluted Share | $6.9B | $6.8B | $7.1B | $7.1B | $7.1B | |
EBITDA | $374.6M | $431M | $510.9M | $463.1M | $547.7M | |
EBIT | $133.5M | $180M | $278.5M | $242.8M | $294.9M | |
Revenue (Reported) | $4.3B | $4.5B | $4.5B | $4.2B | $4.5B | |
Operating Income (Reported) | $120.4M | $119.5M | $255.1M | $211.4M | $183.1M | |
Operating Income (Adjusted) | $133.5M | $180M | $278.5M | $242.8M | $294.9M |
Period Ending | 2013-06-30 | 2014-06-30 | 2015-06-30 | 2016-06-30 | 2017-06-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | $6.3M | $7.6M | $9.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $4.3B | $4.5B | $4.5B | $4.2B | $4.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3.7B | $3.8B | $3.8B | $3.4B | $3.6B | |
Gross Profit | $579.8M | $673M | $767.8M | $807.1M | $878.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $235.1M | $300.8M | $295.7M | $307.7M | $330.1M | |
Selling, General & Admin | $230.5M | $265.9M | $222.7M | $295.5M | $373M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $459.3M | $553.5M | $512.7M | $595.8M | $695.6M | |
Operating Income | $120.4M | $119.5M | $255.1M | $211.4M | $183.1M | |
Net Interest Expenses | -- | $1.7M | $13.7M | $33.2M | $48M | |
EBT. Incl. Unusual Items | $116.5M | $167.3M | $248M | $179.5M | $220.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $73.9M | $30.5M | $77.6M | $49.9M | $66.2M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$66K | $842K | -$723K | -$605K | -$613K | |
Net Income to Common Excl Extra Items | $42.5M | $137.6M | $169.6M | $129M | $153.7M | |
Basic EPS (Cont. Ops) | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 | |
Diluted EPS (Cont. Ops) | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $133.5M | $180M | $278.5M | $242.8M | $294.9M | |
EBIT | $133.5M | $180M | $278.5M | $242.8M | $294.9M | |
Revenue (Reported) | $4.3B | $4.5B | $4.5B | $4.2B | $4.5B | |
Operating Income (Reported) | $120.4M | $119.5M | $255.1M | $211.4M | $183.1M | |
Operating Income (Adjusted) | $133.5M | $180M | $278.5M | $242.8M | $294.9M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $766.1M | $769.4M | $914M | $1.3B | $1.1B | |
Short Term Investments | $125.8M | $98M | $50.8M | $980K | $40.5M | |
Accounts Receivable, Net | $871.5M | $1B | $720M | $807.3M | $909.7M | |
Inventory | $944.1M | $982.4M | $966.8M | $801.8M | $904.3M | |
Prepaid Expenses | $49M | $31.4M | $7.4M | $50.7M | $27M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.8B | $3B | $2.8B | $3.1B | $3.2B | |
Property Plant And Equipment | $766.9M | $880.8M | $789.6M | $937M | $1.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $443.4M | $403.3M | $403.3M | $479.9M | $490.5M | |
Other Intangibles | $304.5M | $263.7M | $224.8M | $288.8M | $304.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $4.6B | $5B | $4.5B | $5.1B | $5.5B | |
Accounts Payable | $673.9M | $773.3M | $971M | $663.1M | $774.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $17M | $8.9M | $7.7M | $11.4M | $9.5M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.8B | $1.9B | $1.5B | $2.6B | $2.2B | |
Long-Term Debt | $574.6M | $575.6M | $574.7M | -- | $633.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.4B | $2.6B | $2.2B | $2.7B | $3B | |
Common Stock | $134.6M | $139.3M | $142.2M | $142.4M | $142.4M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $2.2B | $2.4B | $2.3B | $2.4B | $2.5B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.5M | $1M | $1.6M | $2.6M | $9.9M | |
Total Equity | $2.2B | $2.4B | $2.3B | $2.4B | $2.5B | |
Total Liabilities and Equity | $4.6B | $5B | $4.5B | $5.1B | $5.5B | |
Cash and Short Terms | $891.9M | $867.5M | $964.9M | $1.3B | $1.2B | |
Total Debt | $1.2B | $1.3B | $1B | $1.4B | $1.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $766.1M | $769.4M | $914M | $1.3B | $1.1B | |
Short Term Investments | $125.8M | $98M | $50.8M | $980K | $40.5M | |
Accounts Receivable, Net | $871.5M | $1B | $720M | $807.3M | $909.7M | |
Inventory | $944.1M | $982.4M | $966.8M | $801.8M | $904.3M | |
Prepaid Expenses | $49M | $31.4M | $7.4M | $50.7M | $27M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $2.8B | $3B | $2.8B | $3.1B | $3.2B | |
Property Plant And Equipment | $766.9M | $880.8M | $789.6M | $937M | $1.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $443.4M | $403.3M | $403.3M | $479.9M | $490.5M | |
Other Intangibles | $304.5M | $263.7M | $224.8M | $288.8M | $304.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $4.6B | $5B | $4.5B | $5.1B | $5.5B | |
Accounts Payable | $673.9M | $773.3M | $971M | $663.1M | $774.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $17M | $8.9M | $7.7M | $11.4M | $9.5M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.8B | $1.9B | $1.5B | $2.6B | $2.2B | |
Long-Term Debt | $574.6M | $575.6M | $574.7M | -- | $633.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.4B | $2.6B | $2.2B | $2.7B | $3B | |
Common Stock | $134.6M | $139.3M | $142.2M | $142.4M | $142.4M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.5M | $1M | $1.6M | $2.6M | $9.9M | |
Total Equity | $2.2B | $2.4B | $2.3B | $2.4B | $2.5B | |
Total Liabilities and Equity | $4.6B | $5B | $4.5B | $5.1B | $5.5B | |
Cash and Short Terms | $891.9M | $867.5M | $964.9M | $1.3B | $1.2B | |
Total Debt | $1.2B | $1.3B | $1B | $1.4B | $1.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $116.5M | $167.3M | $248M | $179.5M | $220.5M | |
Depreciation & Amoritzation | $241.1M | $251M | $232.4M | $220.3M | $252.7M | |
Stock-Based Compensation | $7.9M | $4.2M | $3.9M | $868K | $1.1M | |
Change in Accounts Receivable | $164M | -$182.9M | $373.3M | -$65M | -$105.7M | |
Change in Inventories | -$222.3M | -$140.7M | $20.5M | $216.9M | -$18M | |
Cash From Operations | $115.1M | $84.9M | $556.5M | $573.6M | $252.9M | |
Capital Expenditures | $366.8M | $241.2M | $131.4M | $310.6M | $385.7M | |
Cash Acquisitions | -$1.6M | -$49.2M | -$7.4M | -$199M | -$110.7M | |
Cash From Investing | -$355.6M | -$219.8M | -$66.2M | -$410.2M | -$474.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $3.2B | $3.2B | $1.1B | $1.4B | $6.7B | |
Long-Term Debt Repaid | -$3.1B | -$3.2B | -$1.3B | -$1B | -$6.5B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $75M | -- | $424K | $416K | |
Cash From Financing | $71.3M | $119.7M | -$270.2M | $248.6M | $58.8M | |
Beginning Cash (CF) | $892.1M | $766.1M | $769.4M | $914M | $1.3B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$169.3M | -$15.2M | $220.1M | $412M | -$162.9M | |
Ending Cash (CF) | $766.1M | $769.4M | $914M | $1.3B | $1.1B | |
Levered Free Cash Flow | -$251.8M | -$156.3M | $425M | $263.1M | -$132.8M |
Period Ending | 2013-06-30 | 2014-06-30 | 2015-06-30 | 2016-06-30 | 2017-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | $6.3M | $7.6M | $9.1M | |
Depreciation & Amoritzation | -- | -- | $752K | $742K | $889K | |
Stock-Based Compensation | -- | -- | $306K | $406K | $584K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | $8.5M | $9.1M | $9.9M | |
Capital Expenditures | -- | -- | -- | $1.3M | $1.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$43.2M | -$117.6M | -$89.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$2.7M | -$2.8M | -$3.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $12.4M | -- | $31.1M | |
Long-Term Debt Repaid | -- | -- | -$74.6M | -$31.8M | -$8.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $6K | $109K | -- | |
Cash From Financing | -- | -- | $40.2M | $117.2M | $88.4M | |
Beginning Cash (CF) | -- | -- | $41.1M | $42.3M | $48.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | $5.5M | $8.7M | $8.5M | |
Ending Cash (CF) | -- | -- | $46.6M | $51M | $56.7M | |
Levered Free Cash Flow | -- | -- | -- | $7.8M | $8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $115.1M | $84.9M | $556.5M | $573.6M | $252.9M | |
Capital Expenditures | $366.8M | $241.2M | $131.4M | $310.6M | $385.7M | |
Cash Acquisitions | -$1.6M | -$49.2M | -$7.4M | -- | -- | |
Cash From Investing | -$355.6M | -$219.8M | -$66.2M | -$410.2M | -$474.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $3.2B | $3.2B | $1.1B | $1.4B | $6.7B | |
Long-Term Debt Repaid | -$3.1B | -$3.2B | -$1.3B | -$1B | -$6.5B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $75M | -- | -- | -- | |
Cash From Financing | $71.3M | $119.7M | -$270.2M | $248.6M | $58.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$113.9M | -$5.2M | $191.3M | $436.9M | -$159.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$251.8M | -$156.3M | $425M | $263.1M | -$132.8M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.